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TRPV1The Transient Receptor Potential Vanilloid 1 (TRPV1, vanilloid receptor 1) ion channel plays a key role in the per-
ception of thermal and inﬂammatory pain, however, its molecular environment in dorsal root ganglia (DRG) is
largely unexplored. Utilizing a panel of sequence-directed antibodies against TRPV1 protein and mouse DRG
membranes, the channel complex frommouse DRGwas detergent-solubilized, isolated by immunoprecipitation
and subsequently analyzed bymass spectrometry. A number of potential TRPV1 interaction partners were iden-
tiﬁed, among them cytoskeletal proteins, signal transduction molecules, and established ion channel subunits.
Based on stringent speciﬁcity criteria, the voltage-gated K+ channel beta 2 subunit (Kvβ2), an accessory subunit
of voltage-gated K+ channels, was identiﬁed of being associated with native TRPV1 channels. Reverse co-
immunoprecipitation and antibody co-staining experiments conﬁrmed TRPV1/Kvβ2 association. Biotinylation
assays in the presence of Kvβ2 demonstrated increased cell surface expression levels of TRPV1, while patch-
clamp experiments resulted in a signiﬁcant increase of TRPV1 sensitivity to capsaicin. Our work shows, for the
ﬁrst time, the association of a Kvβ subunit with TRPV1 channels, and suggests that such interaction may play a
role in TRPV1 channel trafﬁcking to the plasma membrane.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
TRPV1 is a Ca2+ and Na+-permeable ion channel responding to heat
(N42 °C), acidosis (pH b 6), endovanilloids and a variety of chemicals ofadenosine tris-phosphate; BSA,
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ights reserved.which capsaicin, the pungent component of red hot chili, is best known
[1,2]. This ion channel is predominantly expressed in the peripheral
sensory system, and therefore is in a strategic position to determine
speciﬁcity, speed and modulation of sensory and nociceptive neuro-
transmission [2]. TRPV1 channels are associated with inﬂammatory
pain and thermal hyperalgesia [3]: mice lacking TRPV1 channels are
impaired in the detection of noxious heat, and show impaired thermal
hypersensitivity [3].
TRPV1 is the ancestor of the transient receptor potential vanilloid
channel family, which structurally resembles voltage-gated potassium
channels [4]. Accordingly, these channels are presumed to be constituted
of four identical subunits, each of which having six membrane-spanning
domains (S1–S6) and intracellular carboxyl and amino termini [1].
Recent research indicates that many ion channels are organized in a
multiprotein assembly, termed signaling complexes, where channel
regulation is critically dependent on protein–protein interactions [5].
For instance, proteomic studies on NMDA receptors, or voltage-gated
calcium channels, demonstrated close interaction of multiple polypep-
tides which modulate the ion channel function, some of which have
previously not been identiﬁed of being associated with ion channels
[6,7].
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those of their native counter-parts, for instance, from sensory neurons
[8]. However, the pharmacological proﬁle of these recombinant channels
differs from native channel, giving room for a possible co-association of
accessory regulatory proteins in native channels [8]. Therefore, the pecu-
liarity of TRPV1 channel signaling could be partly due to association of
thus far uncharacterized proteins. In this context, a limited number of
previous studies focused on protein–protein interaction of the pore-
forming subunit TRPV1with potential interaction partners [9–15]. For in-
stance, tubulin was shown to be capable to associate with TRPV1 protein
[9,10], demonstrating direct association of TRPV1 with cytoskeletal ele-
ments. In addition, co-immunoprecipitation and co-staining experiments
indicated an intimate and physiologically relevant interaction of TRPV1
with TRPV2 subunits in rodent dorsal root ganglia (DRG), as well as in
cell lines after recombinant channel expression [12,14]. The protein ki-
nase A anchoring protein 150 (AKAP150) and the phosphoinositide-
binding protein Pirt were also found to associate with TRPV1 channels
[11,15]. The alternative approach of yeast two-hybrid screening identi-
ﬁed two interacting proteins, snapin and synaptotagmin IX, which play
a role in SNARE-dependent exocytosis, suggesting that their interaction
with TRPV1 may modulate aspects of TRPV1 trafﬁcking and/or delivery
to the plasma membrane [13].
In order to deepen our insight into TRPV1 channel assembly, we
embarked on a systematic approach of isolating native TRPV1 channel
complexes through immunoprecipitation with anti-TRPV1 antibodies
and identifying the isolated complex components by mass spectrome-
try. We report the identiﬁcation of the voltage-gated K+ channel acces-
sory subunit beta 2 (Kvβ2) as a novel TRPV1 interacting protein. Thus
far, Kvβ2 was believed to be an exclusive ancillary subunit of voltage-
gated K+ channels (Kv) which is associated with a cytoplasmic domain
on pore-formingKv1 (Shaker) alpha subunits [16]. Their functional con-
tribution was shown to be either conferring an inactivation particle to
the Kv1 channel family [17], or facilitating the trafﬁcking of the Kv1
channel to the plasma membrane [18]. This is the ﬁrst study that dem-
onstrates that Kvβ2 is found in association with structurally different
pore-forming subunits other than Kv channels.
2. Experimental procedures
2.1. Reagents
For immunoprecipitation experiments, two polyclonal sera were
raised and afﬁnity puriﬁed as previously published [19]. The sequences
of the synthetic peptides employed and their location along the rat
TRPV1 sequence are: EDA EVF KDS MVP GEK (anti-TRPV1(824–838))
and EDP GNC EGV KRT LSF SLR (anti-TRPV1(761–778)). The amino acid
numbering refers to the rat TRPV1 clone isoform 1 (accession number:
O35433). An additional rabbit anti-TRPV1 antibody was purchased
from Sigma-Aldrich, directed against amino acids 817–838 of rat and
mouse TRPV1. This antibodywas used for immunostaining andWestern
blotting experiments. Monoclonal anti-Kvβ2 antibody (clone K17/70)
was purchased from NIH Neuromab. Monoclonal anti-c-myc (clone
9E10) was from Sigma-Aldrich. Monoclonal anti-GAPDH-hrp (clone
GAPdh-71.1)was fromSigma-Aldrich.Monoclonal anti-Na+/K+ATPase
α1 (clone C464.6) was from Upstate Biotechnology.
Fluorescently-labeled secondary antibodies, anti-rabbit Alexa ﬂuor-
488 and anti-mouse Alexa ﬂuor-594, were from Invitrogen. Anti-fade
mountingmedia were from Vectashield. High glucose DMEM for cell cul-
ture, poly-L-lysine and laminin were from Sigma-Aldrich. Fetal bovine
serum, trypsin–EDTA, L-glutamine, streptomycin sulfate, and protein
A coated Dynabeads were from Invitrogen. Liberase Blendzyme 1
was from Roche. TNB medium and Protein–Lipid-Complex were from
Biochrom. Streptavidin magnetic beads and Sulf-NHS-LC-LC-Biotin were
from Thermo Scientiﬁc.
Primers for subcloning were from Sigma, pcDNA3.1 and pcDNA3
plasmids were from Invitrogen, and pGFP-c1 plasmidwas from Clontech.Dodecanoyl sucrose was purchased from Merck (Darmstadt,
Germany), mass spectrometry grade trypsin from Promega, and
cell transfection reagent Metafectene Pro was from Biontex.
2.2. Animals
TRPV1 deﬁcientmice (TRPV1−/−) were purchased by Charles River–
Jackson Laboratories (strain B6.129X1-Trpv1tm1Jul/J). TRPV1−/− and
C57Bl/6J wild type (WT) mice were housed and handled in accordance
with the guidelines of the Directive 2010/63/EU for the use of laboratory
animals.
2.3. Cell line culture
The mammalian cell line tsA201 is derived from human embryonic
kidney HEK-293 cells by stable transfection with SV40 large-T antigen
and has been reported to produce high levels of recombinant proteins
[20]. N1E-115-1 cells are derived from mouse neuroblastoma and
have been utilized in a wide range of functional studies [21]. tsA-
201 cells were maintained at 37 °C and 5% CO2 in high glucose
DMEM supplemented with 10% (v/v) fetal bovine serum and 1% (v/v)
penicillin/streptomycin (PAA). Cells were transiently transfected
with Metafectene Pro following manufacturers's guidelines. N1E-115-1
cells were maintained and transfected in the same conditions used for
tsA-201 cells.
2.4. DRG membrane preparation and TRPV1 complex solubilization
DRG membrane fraction was prepared according to Berkefeld et al.
[22] with minor modiﬁcations. Brieﬂy, whole DRG from adult mice
were dissected and collected in PBS containing 3 mM EDTA and 0.5 mM
PMSF. Subsequently, they were homogenized with a glass potter in lysis
buffer (10 mM Tris pH7.4, 1 mM EDTA, 1 mM iodoacetamide, 1 mM
PMSF and protease inhibitors: 2 μM leupeptin, 1.5 μM aprotinin and
0.15 μM pepstatin). Low-speed centrifugation (1000 ×g) was performed
twice to remove cellular debris, resuspending the pellet in lysis buffer in
between. The resulting supernatant was centrifuged at high-speed
(100,000 ×g) 15 min, the membrane fraction pellet was resuspended in
20 mM Tris, and protein concentration was determined. In order to solu-
bilize the TRPV1 protein complex, the membrane fraction was incubated
in solubilization buffer (1% dodecanoyl sucrose (w/v), 150 mM NaCl,
20 mM Tris pH7.4, 1 mM EDTA, 1 mM PMSF and protease inhibitors, in
the same concentration as mentioned above), 30 min on ice. Subsequent
high-speed centrifugation (100,000 ×g) 30 min led to the separation
of non-soluble pellet from a solubilized supernatant. This fraction was
used as starting material for the immunoprecipitation experiment
described below.
2.5. Immunoprecipitation of TRPV1 protein complex
Antibodies immobilized on protein A-coated Dynabeads were incu-
bated with the detergent-solubilized membrane fraction obtained from
mouse DRG (see above) 2 h at 4 °C. 10 μg of antibody was used to pre-
cipitate 300 μg of total membrane extract for analytical experiments.
For mass spectrometric sequencing, 3 mg of total membrane protein
was used as starting material. After immunoprecipitation, the TRPV1
complex was eluted under denaturing conditions (Laemmli buffer
without reducing agent). Thereafter, reducing agent dithiothreitol
(DTT) was added to the sample (ﬁnal concentration of 120 mM). For
MS-sequencing, eluates were shortly run on SDS-PAGE minigels,
stained by silver staining [23], divided into three molecular-weight
ranges and separately subjected to in-gel trypsin digestion according
to Shevchenko et al. [24], with the only modiﬁcation that the gel pieces
were incubated overnight at 37 ° C with trypsin (5 μg/ml).
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Protein digests were analyzed using an UltiMate 3000 nano-HPLC
system (Dionex, Germering, Germany) coupled to an LTQ Orbitrap XL
mass spectrometer (ThermoScientiﬁc, Bremen, Germany) equipped
with a nanospray ionization source. A fritless fused silica microcapillary
column (75 μm i.d. × 280 μmo.d.) packedwith 10 cm of 3 μm reverse-
phase C18 material (Reprosil) was used. The gradient (solvent A: 0.1%
formic acid; solvent B: 0.1% formic acid in 85% acetonitrile) started at
4% B. The concentration of solvent B was increased linearly from 4% to
40% during 67 min and from 40% to 100% during 10 min. A ﬂowrate of
250 nl/min was applied.
Mass Spectrometry (MS) instrument settings were as follows: Mass
spectra were acquired in positive ion mode applying a data-dependent
automatic switch between survey scan and MS/MS acquisition. Survey
MS scans (from m/z 300 to 2000) were acquired in the Orbitrap with
a resolution of R = 60,000; the target value was 200,000; maximum
ionization time was set to 20 ms. Up to four of the most intense ions
per scan were fragmented in the linear trap (LTQ) using collision in-
duced dissociation (CID) at a target value of 10,000; the maximum ion-
ization time was set to 100 ms. Dynamic exclusion settings: repeat
count 1; repeat duration 50 s; exclusion duration was 45 s. Charge
state screening was enabled; unassigned and singly charged ions were
excluded from MS/MS.
Protein identiﬁcation was performed using the Mascot search en-
gine and the NCBInr database (Mus musculus) accepting variable modi-
ﬁcations, carbamidomethyl (C), and oxidation (M). Speciﬁc cleavage
sites for trypsin (KR) were selected with two missed cleavage sites
allowed. Peptide tolerance was +20 ppm and MS/MS tolerance was
+0.8 Da. We selected the candidate peptides with probability-based
Mowse scores (total score) that exceeded its threshold indicating a sig-
niﬁcant homology (P b 0.05). Peptides with a Mascot score below 20
were skipped.
2.7. Primary sensory neuron culture
L1–L6 lumbar dorsal root ganglia (DRG) were dissected from adult
mice as previously published [25]. After removal of connective tissue,
ganglia were incubated in Liberase Blendzyme 1 (9 mg/100 ml DMEM)
for 60 min. After rinsing with PBS, 1× trypsin–EDTA was added for
15 min and DRG were washed with TNB medium supplemented with
L-glutamine, penicillin G sodium, streptomycin sulfate, and Protein–
Lipid-Complex. DRG were dissociated with a ﬁre-polished Pasteur
pipette and centrifuged through a 3.5% BSA gradient to minimize
non-neuronal cells. The sensory neurons were resuspended, plated
on coverslips coated with poly-L-Lysine/laminin-1, and cultivated
in TNB medium at 37 °C in 5% CO2 for 24 h.
2.8. Immunocytochemistry and microscopy
Neuronswere kept for 24 h in culture, ﬁxedwith 4% PFA for 20 min,
permeabilized with 0.1% Triton X-100 (Sigma) 5 min and blocked with
10% goat serum in PBS for 30 min. Cells were incubated with primary
antibodies against TRPV1 and Kvβ2 dissolved in 10% goat serum in
PBS (1:4000 and 1:1000) respectively for 60 min at room temperature
(RT), washed with PBS, and incubated with secondary antibodies
(1:1000) for 30 min at RT. Nuclei were stained with 4′,6-diamidino-2-
phenylindole (DAPI 1:1000 in PBS) and cells were embedded inmount-
ing medium. Neurons were documented applying a Zeiss ﬂuorescence
microscope equipped with a SPOT RT digital camera. Neurons resulting
positive both to TRPV1 and Kvβ2 staining were evaluated. Average cell
ﬂuorescence intensities were measured after background subtraction
applying Metamorph software (MetaMorph®, version 7.5.6, Visitron
Systems). For confocal microscopy, z-stack images were acquired with
Leica SP5 confocal microscope, and analyzed with Huygens Professional
image deconvolution software.2.9. Molecular biology
Kvβ2 cDNA was kindly provided by J. Trimmer. Kvβ2 cDNA was
subcloned in pGEMHE by digesting with XbaI and ClaI, both in the mul-
tiple cloning site, blunting both ends and subcloning into the SmaI site
of pGEMHE. BamHI and EcoRI restriction sites were then attached re-
spectively at the 5′ and 3′ ends of the coding sequence by PCR, and
were used to subclone Kvβ2 into pcDNA3.1-myc-His plasmid. mTRPV1
cDNA cloned into pcDNA3 plasmid was provided by M. Caterina. For
electrophysiology recording, TRPV1 plasmid was co-transfected with
pGFP-C1 plasmid to identify TRPV1 expressing N1E-115-1 cells. The in-
tegrity of all constructs was conﬁrmed by DNA sequencing (Secugen).
2.10. Co-immunoprecipitation in tsA-201 cell line
12 × 105 tsA-201 cells were seeded in 60 mm dishes 24 h before
transfection. For each condition, 5 μg of total cDNA was transfected
and equimolar amounts of cDNA were used in double transfection con-
ditions. The amount of cDNA was kept constant by addition of empty
pcDNA3 plasmid in mock and single transfection conditions. Cells
were harvested 48 h after transfection, washed twice in PBS and lysated
by mechanical trituration (27G syringe needle) in lysis buffer (same as
described in the DRG membrane preparation section) on ice. Centrifu-
gation steps, TRPV1 complex solubilisation and immunoprecipitation
were as described for DRG membranes. The eluates were run on 9%
SDS-PAGE minigels, blotted on PVDF membrane and monitored by
Western analysis with rabbit anti-TRPV1 (0.1 μg/ml) and mouse anti-
myc (1:5000) antibodies.
2.11. Electrophysiology
N1E-115-1 cells were used for electrophysiology 18 to 28 h after
plating on 24 mm coverslips. Ionic currents were recorded in the classi-
cal whole-cell voltage-clamp conﬁguration of the patch-clamp tech-
nique as previously published [21,26,27]. Calcium-free ECS contained:
150 mM NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM glucose, and 10 mM
HEPES, at pH 7.3 adjusted with NaOH. Calcium was removed to avoid
desensitization of capsaicin-induced currents. Borosilicate glass pipettes
(Science Products) pulled with a horizontal puller (Sutter Instruments
Company) were ﬁlled with internal solution (ICS): 148 mM KCl, 2 mM
MgCl2, 2 mM MgATP, 0.1 mM CaCl2, 1 mM EGTA, and 10 mM HEPES,
at pH 7.3 adjusted with KOH. After ﬁlling, electrode resistance was
2–4 MΩ. N1E-115-1 cells were recorded at 0 mV holding potential,
and to monitor TRPV1 channel activation the cells were challenged by
a 200 ms voltage ramp from −100 to +100 mV every 2.5 s. Currents
were sampled at 50 kHz and ﬁltered at 2.9 kHz, and recorded with an
EPC10 (HEKA) and the Pulse v8.74 software (HEKA). A ten barrel sys-
tem with common outlet was used for fast drug administration (WAS
02, Dittel, Prague). Capsaicin-activated currents (Icaps) were elicited
by applying increasing concentrations of capsaicin (Sigma) for 10 s
followed by a 60 s washout with control solution. Experiments were
performed at room temperature and only a single N1E-115-1 cell was
tested per coverslip. Capsaicin dose–response curves were ﬁtted with
a Boltzmann equation (Origin Pro 7, OriginLab).
I ¼ Imaxþ Imin−Imax
1þ e Caps½ −EC50ð Þ=d Caps½ 
Slope ¼ Imax−Imin
4  d Caps½ 
Mann–Whitney U-test was used to determine statistical signiﬁcance.
2.12. Biotinylation assay
Biotinylation and isolation of transfected tsA-201 cells were
performed as described previously [28] with minor modiﬁcations.
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dissolved in water for 30 min at 4 °C. The reaction was quenched by in-
cubating the cells with 10 mM Tris, pH 7.4, 150 mMNaCl for 30 min at
4 °C. Thereafter, the cells were harvested, incubated for 60 min at RT in
lysis buffer (50 mMHepes pH 7.4; 140 mMNaCl; 10% v/v Glycerol; 1%
v/v Triton X-100; 1 mMEDTA; 2 mMEGTA, 0.5% deoxycholate and pro-
tease inhibitors) and centrifuged 15 min at 15,000 ×g. For each inde-
pendent experiment the protein concentration was determined by the
Nanodrop method. Supernatant was incubated overnight at 4 °C with
streptavidin magnetic beads. The precipitated material was eluted in
Laemmli buffer, run on SDS-PAGE minigels and blotted on PVDF mem-
brane. The membrane was then split and subjected toWestern blotting
analysiswith rabbit anti-TRPV1 (0.1 μg/ml), rabbit anti-Na+/K+ATPase
α1 (1:1000), and anti-GAPDH-hrp antibodies (1:10,000). GAPDH was
used as an internal loading control for the total protein lysates, while
Na+/K+ channel protein served as a loading control for the surface pro-
tein fraction. A rectangular region of interest was drawn in a way to
include all TRPV1 glycosylation products (90 kDa and 105–110 kDa
bands). The resulting density value was then normalized according to
the density of the loading controls (GAPDH or Na+/K+). FujiFilm Las-
1000was used for image acquisition, NIH-ImageJ for image densitometry.3. Results
3.1. Mass spectrometry analysis shows that Kvβ2 is speciﬁcally
immunoprecipitated in association with TRPV1 channels
Previous studies indicated that TRPV1 channels are organized, like
many other ion channels, in multiprotein signaling complexes [9–15].
In order to identify novel components of native TRPV1 channels, we
embarked on a so far unexplored and rigorous biochemical approach
of detergent-solubilizing TRPV1 channels frommouse DRGmembranes,
isolating the complex by immunoprecipitation and sequencing the
harvested material by mass spectrometry. Initial experiments focused
to establish the precise conditions of detergent solubilization. We aimed
to optimize high solubilization efﬁciency of TRPV1 protein thereby using
fairly mild solubilization conditions. A number of different detergents
(lauroylsarcosine, digitonin, CHAPS, Triton X-100, SDS) and experimental
conditions (incubation time, temperature, detergent concentration and
protein:detergent ratio) were screened. Dodecanoyl sucrose was chosen
as it performed best in our solubilization assay resulting in nearlyinp
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Fig. 1. Immunoprecipitation of TRPV1 protein.Western blotting of TRPV1 immunoprecip-
itation from solubilized mouse DRG membrane fraction with anti-TRPV1(824–838) anti-
body, monitored with anti-TRPV1(817–838) antibody. Parallel experiments were run with
immunoprecipitated material fromWT and the TRPV1−/− (KO) mice. For each condition,
the following fractionswere loaded on a gel: DRGmembrane (input), non-soluble (pellet)
and solubilized (soluble), non-bound material (ﬂow-through) and eluate.quantitative solubilization of membrane protein as determined by
Western blotting (Supplemental Fig. 1). This detergent is fairly mild
(large, non-polar head group and a C12 aliphatic tail) with a low critical
micelle concentration (CMC 0.30 mM), and is expected to show good
preservation of the native molecular environment of an ion channel. We
also set out to optimize our immunoprecipitation approach with respect
to ionic strength and incubation time, using Western blotting experi-
ments as read-out. Parallel experiments utilizingDRG fromTRPV1−/−de-
ﬁcient animals served as negative controls. Under these conditions TRPV1
channels were quantitatively immunoprecipitated as the remaining
supernatant was virtually devoid of TRPV1 channel protein (Fig. 1).
After having established suitable solubilization and immunoprecipi-
tation conditions, membranes derived from approximately 100 mouse
DRG were dodecanoyl sucrose-solubilized and immunoprecipitated as
described under Experimental procedures. The immunoprecipitated
material was quantitatively recovered from the antibody matrix after
SDS denaturation. As a high concentration of SDSwould have precluded
subsequent trypsinization of the precipitated material, excess SDS
was removed by gel electrophoresis, the isolated material was in-
gel trypsinized, and the resulting peptide-fragments were analyzed
by mass spectrometry. Several stringent criteria were adopted to
minimize the occurrence of false-positive candidates: ﬁrstly, parallel ex-
periments were performed using DRGmembranes from TRPV1−/− deﬁ-
cient mice. Tryptic peptide fragments corresponding to proteins that
were also detected in TRPV1−/− samples were excluded from further
analysis. Secondly, every peptide ascribed to the IgG family was excluded
from further analysis, as well as any peptide deriving from either trypsin
autodigestion or keratins. Thirdly, proteins that were identiﬁed by less
than two peptides were not taken into further account. The list of pro-
teins resulting from mass spectrometric sequencing is shown in Table 1.
Out of this list of potential TRPV1 interaction partners (Table 1), two
proteins attracted our attention. TRPV2 protein was identiﬁed with high
consistency, in accordance with previously published data [12,14],
strengthening the validity of our approach. In addition, Kvβ2 was
also consistently immunoprecipitated together with TRPV1 channel.
By itself, we considered this ﬁnding quite remarkable as this protein
was so far only characterized of being intimately associatedwith a num-
ber of voltage-gated potassium channels of the Kv1 family [17,18]. This
result suggested that Kvβ2 could serve to be integral component of the
TRPV1-associated protein complex probably accounting for discrete
functional properties of native TRPV1 channels, and prompted us to
further characterization.
3.2. TRPV1 and Kvβ2 co-assemble after recombinant expression
In order to conﬁrm that Kvβ2 protein is an interaction partner of
TRPV1 channels, the two proteins were co-expressed in tsA-201 cellsTable 1
Proteins identiﬁed by mass spectrometry sequencing of the material precipitated in
association with TRPV1 protein, and associated Mascot score. All proteins depicted
were only found in wild-type samples. The presence of a tryptic peptide fragment
in a TRPV1−/− sample resulted in exclusion of the protein for further analysis.
Protein Accession number Mascot score
TRPV1 gi47825364 1356
TRPV2 gi134053865 276
Kvβ2 gi975314 103
Actin gi30425250 121
Rab-8B gi27734154 78
Apolipoprotein O gi81906185 88
Glycogen phosphorylase gi6755256 51
Alpha-fodrin gi930145 130
Cadherin 1 gi6753374 85
Zonula occludens protein 1 gi732430 85
U1 snRNP gi67846113 59
Ribosomal protein L9 gi687604 108
Glucose 6 phosphatase gi28395061 111
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nant means should allow stable complex formation which then could
be veriﬁed by co-immunoprecipitation. TsA-201 cells were transiently
transfected with plasmids encoding the cDNA sequences of TRPV1 and
myc-tagged Kvβ2. Co-immunostaining experiments reveal a large de-
gree of colocalization of both proteins (Supplemental Fig. 2). Neither
TRPV1 nor Kvβ2 was detected in control mock-transfected cells, indi-
cating that this expression system is largely devoid of these proteins.
Western blots served as read-outs after detergent solubilization and
immunoprecipitation. As shown in Fig. 2A, material precipitated by
the anti-myc antibody (which will react with Kvβ2) contained Kvβ2input input
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part with anti-myc antibody. Panel A shows double-transfected cells. Black arrows indicate co-
myc antibody (top), andmyc-Kvβ2 band in the material precipitated with anti-TRPV1 antibody
(left), TRPV1 protein (middle) andmyc-tagged Kvβ2 protein (right). FT: ﬂow-through. Panel C
in tsA-201 cells (left), or frommouse DRG (right) are shown. For each condition,membrane lys
(−) were loaded on the gel. Each PVDF membrane was cut horizontally and monitored with a
signal, green asterisk indicates non-glycosylated TRPV1. Western blotting detection was perforprotein as well as signiﬁcant amounts of TRPV1 protein. Conversely,
our anti-TRPV1 antibodies precipitated also Kvβ2 material. Protein ex-
tracts of cells solely transfected with either TRPV1 ormyc-Kvβ2 protein
served as controls. Under these conditions, the respective antibodies did
only precipitate their respective recombinant immunogenes, and
did not display any cross-reactivity (Fig. 2B). These data demon-
strate that TRPV1 and Kvβ2 are also capable to speciﬁcally co-
assemble in vitro, in support of the mass spectrometry results
obtained with DRG membranes.
Interestingly, Western blots of recombinant TRPV1 protein revealed
a band pattern slightly different from native DRG TRPV1 protein. Asinput
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ing material (input) and immunoprecipitated material with anti-TRPV1 and anti-myc an-
oretic separation. In each panel, top part was revealed with anti-TRPV1 antibody, bottom
immunoprecipitation signals: TRPV1 signal present in the material precipitated with anti-
(bottom). Panel B shows speciﬁcity controls: cells transfected with mock empty plasmid
: Western blots of membrane protein extracts from either TRPV1 protein after expression
ates (input), treatedwith N-glycanase enzyme (+), or incubated in absence of the enzyme
nti-TRPV1(817–838) and anti-GAPDH antibodies. Red asterisk indicates glycosylated TRPV1
med using a digital Peqlab imager.
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visible in addition to the expected size of TRPV1 protein (90 kDa). We
considered this 105 kDa band to reﬂect TRPV1 proteinwith a higher de-
gree of N-linked glycosylation in accordance with previous expression
studies in HEK293 and in DRG-derived F11 cell lines [29]. In order to
test this hypothesis, we carried out deglycosylation studies. As shown
in Fig. 2C, enzymatic digestion of protein lysates with N-glycanase
resulted in a molecular weight shift of TRPV1 protein in both, native
and recombinant channels. After deglycosylation, only a 90 kDa bandB
TRPV1 β2vK
WTA
TRPV1
β2vK
merge
Fig. 3. Double immunostaining of TRPV1 and Kvβ2 in cultured sensor neurons. Panel A: represe
fromWT (left) and TRPV1KO (right)mice. TRPV1 (green) staining indicates positive neurons in
ing (red) does not show substantial difference betweenWT and TRPV1 KO. Inmerge panel, neu
indicate co-expressing neurons. Panel B: One example of nucleus-level slice of confocal z-stack(green asterisk) was present indicating that the higher molecular
weight bands are actually TRPV1 protein glycosylation products (red
asterisk).
3.3. TRPV1 and Kvβ2 co-distribute in DRG neurons in primary culture
In order to investigate the co-distribution of TRPV1 andKvβ2 protein
in native neurons, we stained dissociated DRG neuronswith the respec-
tive anti-TRPV1 and anti-Kvβ2 antibodies, and monitored antibodyegrem
ntative picture of conventional ﬂuorescence immunostaining of 24 h DRG neuron culture
WTneurons, while only background staining is detected in TRPV1KO cultures. Kvβ2 stain-
rons co-expressing TRPV1 and Kvβ2 are shown. Cell nuclei are stained in blue, arrowheads
of WT mouse DRG neuron.
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Fig. 4. Biotinylation of surfacemembrane proteins shows an increase of TRPV1protein ex-
pression at the cell surface in presence of Kvβ2.Western blotting of TRPV1 protein in total
lysate (Panel A) and biotinylated surface fraction (Panel B) of cells expressing solely
TRPV1 protein or TRPV1 and Kvβ2. GAPDH served as loading control for the total lysate,
Na+/K+ ATPasewas used for the surfacemembrane protein fraction. Panel C: the increase
of TRPV1 protein cell surface expression in presence of Kvβ2 is expressed as a ratio be-
tween the amount of TRPV1 protein detected at the cell surface and in the total lysate
(TRPV1surface/TRPV1total). P value indicates statistical signiﬁcance after Student's one tailed
t-test, N = 4. Error bars indicate standard error of the mean.
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tures of TRPV1−/− deﬁcient mice were used as speciﬁcity controls. In
accordance with previous studies [30], TRPV1 was observed mostly in
small DRG neurons (18–30 μm), with an average diameter of 24.3 ±
7.9 μm (mean value ± SD, N = 4, n = 226). Out of all inspected
neurons, 47.1 ± 8.9% displayed expression of TRPV1 immunoreac-
tivity, while 38.5 ± 16.6% were positive for Kvβ2 staining. Moreover,
63.5 ± 20.7% of the neurons presenting TRPV1 immunoreactivity
were also found to co-stain for Kvβ2 protein. Conversely, approxi-
mately 78.5 ± 7.1% of Kvβ2 expressing neurons were also positive
for TRPV1 protein staining. This ﬁnding indicates that approximately
30.4% of DRG neurons do co-express both proteins under our exper-
imental conditions.
In order to visualize the distribution of TRPV1 protein and Kvβ2 pro-
tein at higher spatial resolution, we performed confocal immunoﬂuores-
cence microscopy. As shown in Fig. 3B, discrete co-localizing vesicles
were observed in the cytoplasm, presumably representing newly synthe-
sized channel subunits located in the ER/golgi compartment. In addition,
TRPV1 immunoreactivity was also detected in the plasma membrane.
Taken together, these data indicate that TRPV1 and Kvβ2 proteins are
co-expressed in a subpopulation of sensory neurons, and show discrete
co-localization towards vesicle-like entities presumably associated with
endomembranes.
3.4. Kvβ2 protein increases cell surface expression of TRPV1 channel
Earlier studies established the Kvβ2 subunit to exert chaperone-like
effects on various Kvα subunits, resulting in increase of cell surface
expression [18,31–33]. Thus, we reasoned that Kvβ2 protein could con-
tribute to increase cell surface expression of TRPV1 channel protein. In
order to address this question, we performed cell surface biotinylation
assays in the absence and presence of co-expressed Kvβ2 protein and
monitored the level of biotinylated TRPV1 protein bymeans ofWestern
blotting. GAPDH served as a loading control. As shown in Fig. 4A, Kvβ2
co-expression did not inﬂuence the TRPV1 protein overall expression
levels. However, isolating the biotinylated surface protein fraction by
streptavidin afﬁnity chromatography indicated a 2.5 ± 0.6-fold increase
(mean ± sem) of TRPV1 protein residing at the cell surface membrane
after co-expression of Kvβ2 (Fig. 4B, C). As GAPDH was absent in the
cell surface protein fraction (indicating assay speciﬁcity), monitoring of
Na+/K+ATPase served as loading control for the biotinylated surface frac-
tion. These results suggest that Kvβ2 subunit is likely to play a chaperon-
like role on TRPV1 protein, perhaps facilitating the trafﬁcking of the ion
channel to the cell surface.
3.5. Functional characterization of the TRPV1-Kvβ2 complex
After having established Kvβ2 protein to serve as an interaction part-
ner of TRPV1 channels, we next investigated the functional implication of
this interaction. We addressed this question by means of patch clamp
studies recording capsaicin-activated currents (Icaps) in N1E-115-1
cells, as previously published [21,26,27], after heterologous expression
of TRPV1 cDNA in the absence or presence of Kvβ2 cDNA. Capsaicin ac-
tivation of TRPV1 channels expressed in N1E-115-1 cells resulted in the
expected outward rectifying IV-relationship, as shown in Supplemental
Fig. 3,which is indicative of activation of the non-speciﬁc cation channel
TRPV1. In order to minimize capsaicin-dependent desensitization due
to prolonged capsaicin exposure, we addressed the capsaicin dose de-
pendency by applying a ramp-shaped depolarization from −100 mV
to +100 mV. Capsaicin activated TRPV1 channels expressed in N1E-
115-1 cells with an EC50 of 156.62 ± 21.51 nM (mean ± sem, n = 9)
at−60 mV (Fig. 5B). At this negative voltage, capsaicin (1 μM) ac-
tivated an inward current of −9.780 ± 0.512 nA, which did not
further increase at higher capsaicin concentrations (Fig. 5A). At
positive voltage (+80 mV) the EC50 was 133.22 ± 17.91 nM and1 μM capsaicin elicited a maximal outward current of 12.886 ±
0.725 nA (Fig. 5A and B).
When co-expressing TRPV1 together with Kvβ2 in N1E-115 cells,
the Icaps at both negative and positive holding potentials at saturating
capsaicin concentrations did not differ fromN1E-115-1 cells expressing
TRPV1 alone (at 1 μM: inward; −9.996 ± 0.621 nA and outward;
12.878 ± 0.819 nA, n = 12). Furthermore, the size (34.37 ± 2.19 pF
vs. 39.65 ± 2.60 pF) and the current densities of TRPV1 alone
or TRPV1-Kvβ2 expressing cells at saturating capsaicin (≥1 μM)
concentrations were not signiﬁcantly different (at 1 μM Capsaicin: at
−60 mV; −291.10 ± 21.22 vs. 270.54 ± 32.11 pA/pF and at
+80 mV; 386.15 ± 28.90 vs. 349.90 ± 43.06 pA/pF, Fig. 5).
Interestingly, the EC50 of the capsaicin dose response curves at both,
−60 mV and +80 mV was signiﬁcantly shifted to the left by co-
expression of Kvβ2 (74.61 ± 8.37 and 62.79 ± 5.82 nM respective-
ly, Fig. 5A and B) indicating an increased TRPV1 sensitivity for capsa-
icin in the presence of Kvβ2. Also, co-expression of Kvβ2 increased
the slope of capsaicin dose–response curves of Icaps (Fig. 5B).
Fig. 5. Patch clamp recordings of capsaicin-activated currents in presence and in absence of Kvβ2. Panel A: dose response curve of TRPV1 capsaicin-activated inward current at−60 mV
(left) and outward current at +80 mV (right) in presence (red circles) or in absence (black squares) of Kvβ2. The curve presents a decreased EC50 (Panel B) and increased slope (Panel C)
in presence of Kvβ2, both at negative (−60 mV) and positive (+80 mV) potentials. Total capacitance does not change signiﬁcantly (Panel D). Hill coefﬁcients are as follows:−60 mV,
TRPV1 = −2.2 ± 0.2, TRPV1 + Kvβ2 = −2.9 ± 0.2; +80 mV, TRPV1 = 1.8 ± 0.1, TRPV1 + Kvβ2 = 2.2 ± 0.2. Error bars indicate standard errors of the mean, n = 9, * stands for
P value b0.05, ** stands for P value b0.01.
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4.1. Kvβ2 protein is associated with TRPV1 channel
Increasing evidence implies that TRPV1 channels are actively
interacting with cellular proteins that modulate their activity and/or
trafﬁcking to the cell membrane [11,15,34]. The formation of such
multi-protein complexes is expected to exert signiﬁcant effects on the
function of TRPV1 channels, as they could alter its gating and activation
threshold. Thus, the identiﬁcation and characterization of novel interac-
tion partners is essential for a full understanding of the physiology of
this ion channel. In this project we have tackled this goal by a combined
approach of detergent-solubilization of TRPV1 channels derived from
mouse DRG, protein complex immunoprecipitation and component
sequencing by mass spectrometry. We isolated Kvβ2 protein, a so far
unknown component of the TRPV1 channel complex which tightly as-
sociates with TRPV1 protein in both, heterologous expression system
and native DRG neurons, as evidenced by immunoprecipitation assays
and immunocytochemical approaches. Our experiments identiﬁed a
number of additional TRPV1 interaction partners (Table 1), among
them TRPV2 channel subunits. TRPV2 channel protein is accepted of
being capable to form functional heterotetramers with TRPV1 [12,14],
a fact which draws additional validity for the experimental approach
chosen. Surprisingly, we failed to provide a clear demonstration of
some of the previously characterized association partners, such as pro-
tein kinase A anchoring protein 150 (AKAP150) [15] and Pirt [11]. Thereason for this lack of detection is currently unknown; however, different
detergent solubilization protocols could partly explain this discrepancy
as Triton X 100 was used in all previous studies, while we employed
dodecanoyl sucrose.
Kvβ2 protein was initially identiﬁed as an accessory subunit of dif-
ferent Kv1 channels (for a review see Pongs and Schwarz [16]). Two
predominant functions have been proposed for ancillary subunits of
voltage-gated K+ channel. Firstly, Kvβ subunits signiﬁcantly contribute
to the maturation and cell membrane trafﬁcking of the pore-forming
Kv1 subunit [16,18,35]. Secondly, the association of Kv1 channels with
Kvβ2protein has amarked inﬂuence on their gating properties [17,36,37]
as well as pharmacological proﬁle [38,39]. We have addressed the ques-
tion whether any of these established functions of Kvβ2 protein are con-
served for TRPV1 channels. The analysis of the relative amount of TRPV1
channel expressed at the cell surface clearly indicates that Kvβ2 protein
expression leads to an increased amount of TRPV1 channel residing at
the plasma membrane. Our co-immunoprecipitation data and the
co-staining experiments in DRG neuron indicate an intimate – if
not direct – interaction of the two proteins, and point towards the
involvement of Kvβ2 protein in the transport of TRPV1 channel to
the plasma membrane. This role could be partly similar for what
was described by Shi et al. [18], who elucidated how Kvβ2 protein
facilitates the trafﬁcking of Kv1.2 channel to the cell membrane. As
the subunit interaction domain in Shaker-type Kv1 channels was
established by Gulbis [40], we searched for sequence homologies be-
tween this ion channel family and TRPV1. However, we were unable
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different Kvβ2 binding site may be involved. In addition, we did
not observe any Kvβ2-dependent modiﬁcation in the glycosylation
pattern of TRPV1 channel (data not shown), which was observed
by Shi et al. for Kv1.2 channels [18].
We have also investigated the effect of Kvβ2 on the gating properties
of TRPV1 channel by measuring capsaicin-mediated currents in the ab-
sence or in the presence of Kvβ2 subunit. Our data show that Kvβ2
subunit renders TRPV1 channel signiﬁcantlymore sensitive to capsaicin.
Similar effects were previously demonstrated for the Kvβ2 subunit, as
reports have also shown that this protein is capable of altering drug
pharmacology of Kv channels [38,39]. As an explanation for this ef-
fect, Kvβ2 protein could induce an allosteric change in the TRPV1
tri-dimensional conformation, resulting in an increased response to
capsaicin. However, our patch-clamp recordings donot reveal an increase
in capsaicin-mediated current density accompanying the increase in
the cell surface expression of TRPV1 channel. This observation could be
explained by the fact that the increased number of TRPV1 channel ex-
posed at the cell surface of transfected cells might not necessarily reﬂect
a pool of fully functional TRPV1 homotetramers. Similar effects were ob-
served in heterologous TRPV1 expression studies [34,36,41,42]. Lilja et al.
have shown in TRPV1 expressing SH-SY5Y cells that TRPV1 surface ex-
pression was increased in insulin- and IGF-I-treated cells compared to
untreated, and EC50 values alsowere lowered, indicative of a sensitization
[42]. However, similar to what we observe in our present study, the
maximal response in Ca2+ inﬂux was not signiﬁcantly increased in
insulin- and IGF-I-treated cells. Plausibly, this might also be the case
for Kvβ2-mediated sensitization, although mechanistic explanation of
the observed results will have to await further experiments.
4.2. Kvβ2 as a molecular scaffold?
Kvβ2 could also serve a novel yet unidentiﬁed role in the TRPV1
channel complex. As Kvβ2 appears to possess high afﬁnity for both,
voltage-gated K+ channels as well as TRPV1, it seemed feasible that it
may serve an interaction scaffold between these two ion channels bring-
ing them in close spatial proximity. Kv1.4 appears to be the prime candi-
date for such a multichannel complex, as it was previously shown to be
highly expressed in small diameter DRG neurons [43] and, more impor-
tantly, to form a stable complex with Kvβ2 [44,45]. Such Kv1.4/TRPV1/
Kvβ2 complexwould be expected to assemble in the ER-Golgi compart-
ment, and to be subsequently transported to axonal termini, where
both, TRPV1 and Kv1.4 channels were previously shown to be targeted
to [43]. A similar function of Kvβ2 was previously demonstrated
for Kv1.2 [31,46], which is also detected in the axonal compartments
(e.g. juxtaparanode or cerebellar Pinceau terminals [47,48]).
What might be the functional implication of such a putative ion
channel complex? This ion channel assembly could provide a struc-
tural basis of a rapid hence spatially restricted repolarization path-
way. A depolarizing Na+/Ca2+ inﬂux through TRPV1 channel would
be counteracted by a fast repolarizingK+ efﬂux through Kv1.4 channels.
Despite signiﬁcant experimental effort, we could not demonstrate this
interaction by means of immunoprecipitation and subsequentWestern
blotting or mass spectrometric protein sequencing because of its non-
existence, or, if existing, a very subtle and transient interaction, which
wasweakened by the solubilization protocol employed. However, addi-
tional experiments will certainly address this yet unexplored question
in further detail.
4.3. Possible role of Kvβ2 as a redox sensor?
An alternative role for Kvβ2 protein could be its function as oxy-
gen sensor. Kvβ2 was previously shown to belong to the aldo-keto-
reductase superfamily, and was demonstrated to display an enzy-
matic redox activity in permanent association with NAPDH cofactor
[49,50]. This redox reaction catalyzed by Kvβ2 affects Kv1 channelfunction, resulting in a decrease of the inactivating rate of the ion
channel [50]. Therefore, Kvβ2 protein is often referred to as a redox sen-
sor, being able modulate the activity of the channel in response to
changes in the redox environment. Importantly, TRPV1 was shown to
undergo redox modulation, eliciting stronger heat-activated currents
in the presence of both reducing and oxidizing agents [51]. Taken to-
gether, these observations suggest that a possible interpretation for
the functionality of the protein–protein interaction that we describe
herein could be that Kvβ2 senses redox changes in cytoplasmic environ-
ment and transmits this information to the associated TRPV1 channel,
which would in turn undergo conformational changes leading to
increased heat sensitivity. Therefore, changes in the redox state in
a variety of pathophysiological conditions, such as tissue damage and
inﬂammation, might contribute to modulate TRPV1 activity and result
in nociceptor sensitization.
In summary, our results are consistent with the notion that Kvβ2
subunit is a novel interaction partner of TRPV1 protein in mouse DRG.
In vitro data suggest for Kvβ2 a chaperon-like role on TRPV1 channels,
increasing their surface expression, as well as a sensitizing effect of
TRPV1 channels in response to capsaicin. This subunit association could
also be involved in proper TRPV1 channels targeting to axonal compart-
ments, although additional work is required to reveal the effect of such
interaction in vivo.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2013.09.001.Acknowledgements
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